339 related articles for article (PubMed ID: 29253087)
21. The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis.
Zhai Y; Wang J; Jiang Y; Wu W; Lv Y; Xu H; Tian L; Sun H; Zhao Z; Li L
Expert Rev Hematol; 2022 Mar; 15(3):265-272. PubMed ID: 35152814
[TBL] [Abstract][Full Text] [Related]
22. Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis.
Girard L; Koh YJ; Koh LP; Chee YL; Chan HL; Lee J; de Mel S; Poon LM; Samuel M
Bone Marrow Transplant; 2024 Jun; 59(6):838-848. PubMed ID: 38443704
[TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.
Mehta N; Maragulia JC; Moskowitz A; Hamlin PA; Lunning MA; Moskowitz CH; Zelenetz A; Matasar MJ; Sauter C; Goldberg J; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):664-70. PubMed ID: 24035712
[TBL] [Abstract][Full Text] [Related]
24. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D
Haematologica; 2022 Nov; 107(11):2675-2684. PubMed ID: 35320921
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Mamez AC; Dupont A; Blaise D; Chevallier P; Forcade E; Ceballos P; Mohty M; Suarez F; Beguin Y; Peffault De Latour R; Rubio MT; Tournilhac O; Nguyen S
J Hematol Oncol; 2020 May; 13(1):56. PubMed ID: 32429979
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome.
Yang DH; Kim WS; Kim SJ; Bae SH; Kim SH; Kim IH; Yoon SS; Mun YC; Shin HJ; Chae YS; Kwak JY; Kim H; Kim MK; Kim JS; Won JH; Lee JJ; Suh CW
Biol Blood Marrow Transplant; 2009 Jan; 15(1):118-25. PubMed ID: 19135950
[TBL] [Abstract][Full Text] [Related]
27. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
[TBL] [Abstract][Full Text] [Related]
28. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
[TBL] [Abstract][Full Text] [Related]
29. High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.
Gui L; Shi YK; He XH; Lei YH; Zhang HZ; Han XH; Zhou SY; Liu P; Yang JL; Dong M; Zhang CG; Yang S; Qin Y
Int J Hematol; 2014 Jan; 99(1):69-78. PubMed ID: 24258711
[TBL] [Abstract][Full Text] [Related]
30. The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.
Noring K; Carlsten M; Sonnevi K; Wahlin BE
BMC Cancer; 2021 May; 21(1):500. PubMed ID: 33947353
[TBL] [Abstract][Full Text] [Related]
31. Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis.
Yang P; Cai M; Cao Y; Fan S; Tang W; Ji M; Huang L; Wang F; Zhao W; Niu T; Mo X
Br J Haematol; 2024 Apr; 204(4):1414-1421. PubMed ID: 38272453
[TBL] [Abstract][Full Text] [Related]
32. Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?
Lunning MA; Horwitz S
Curr Treat Options Oncol; 2013 Jun; 14(2):212-23. PubMed ID: 23568456
[TBL] [Abstract][Full Text] [Related]
33. Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.
Yin J; Wei J; Xu JH; Xiao Y; Zhang YC
Acta Haematol; 2014; 131(2):114-25. PubMed ID: 24158006
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.
Chen AI; McMillan A; Negrin RS; Horning SJ; Laport GG
Biol Blood Marrow Transplant; 2008 Jul; 14(7):741-7. PubMed ID: 18541192
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
36. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
[TBL] [Abstract][Full Text] [Related]
37. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; León A; Marín J; Bendandi M; Albo C; Caballero MD
Ann Oncol; 2007 Apr; 18(4):652-7. PubMed ID: 17229774
[TBL] [Abstract][Full Text] [Related]
38. Stem cell transplantation for peripheral T-cell lymphomas.
Jantunen E; D'Amore F
Leuk Lymphoma; 2004 Mar; 45(3):441-6. PubMed ID: 15160904
[TBL] [Abstract][Full Text] [Related]
39. Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis.
Gao H; Wu M; Hu S; Ding N; Ji X; Mi L; Wang X; Song Y; Zhu J; Liu W
Front Oncol; 2022; 12():1039888. PubMed ID: 36465366
[TBL] [Abstract][Full Text] [Related]
40. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
Jantunen E; Wiklund T; Juvonen E; Putkonen M; Lehtinen T; Kuittinen O; Franssila K; Söderström KO; Leppä S; Elonen E; Remes K; Nousiainen T
Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
